LOGIN  |  REGISTER
Assertio

Latest Health Technology Stock News

Mangoceuticals Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

July 12
Last Trade: 0.37 0.03 7.25

DALLAS, TEXAS, July 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the areas of erectile dysfunction (ED), hair growth, weight loss, and hormone replacement therapies, is pleased to announce that it has appointed Dr. Douglas Christianson, N.D. to serve as Director of the Medical...Read more


Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

July 11
Last Trade: 41.97 0.69 1.67

Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals LANCASTER, Calif. / Jul 11, 2024 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced a newly funded research...Read more


Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

July 11
Last Trade: 0.35 -0.02 -6.03

LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces a collaboration with the Steno Diabetes Center (‘Steno’), Copenhagen, to advance translation of precision medicine solutions for patients with...Read more


Ian T. Clark Joins GoodRx Board of Directors

July 10
Last Trade: 7.71 -0.32 -3.99

Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx SANTA MONICA, Calif. / Jul 10, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the election of Ian T. Clark to its Board of Directors. Mr. Clark brings to GoodRx over 35 years of experience in the pharmaceutical...Read more


Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the second half of...Read more


Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence

July 9
Last Trade: 5.44 0.01 0.18

FRAMINGHAM, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of a redesigned mobile app for its popular View Suite platform. The new DH View Suite mobile app provides sales and marketing professionals with on-demand access to vital data and intelligence, maximizing their efficiency and success in the field. “In today's healthcare sales...Read more


Kovo HealthTech Announces Departure of Greg Noble as CEO and Appointment of Brenner Adams as Interim Successor

July 9
Last Trade: 0.03 0.00 0.00

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) ("Kovo" or the "Company") today announced that Mr. Greg Noble has stepped down as Chief Executive Officer and that the Board of Directors has selected Brenner Adams to succeed Mr. Noble as interim CEO. During his tenure, Mr. Noble led the Company's public listing on the TSX Venture Exchange and oversaw several acquisitions and...Read more


India-Based Dhiti Omics is Now Live on SOPHiA DDM™

July 4
Last Trade: 4.66 -0.05 -1.06

The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland, July 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...Read more


Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results

July 2
Last Trade: 41.97 0.69 1.67

Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance LANCASTER, Calif. / Jul 02, 2024 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today reported...Read more


Streamline Health® Announces New eValuator™ Contract with 750-Bed Academic Medical Center

July 2
Last Trade: 0.50 0.006 1.21

ATLANTA, July 02, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of eValuator with a 750-bed, Epic-EHR based medical center in Texas. During the pursuit of this relationship eValuator was TX-RAMP certified, enabling Streamline to pursue business with all...Read more


HEALWELL AI Announces Successful Closing of Two Strategic Acquisitions: VeroSource Solutions and BioPharma Services

July 2
Last Trade: 2.38 0.00 0.00

HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL's proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL's profitability. Serving five different provincial health clients across Canada, VeroSource is an end-to-end, customizable, cloud-based data interoperability platform that enables...Read more


Accolade Announces Results for Fiscal First Quarter 2025

June 27
Last Trade: 3.46 0.04 1.17

SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving outcomes for the millions of lives we service. We will continue to push our leadership in Healthcare AI and a proven engagement model that is driving...Read more


New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies

June 27
Last Trade: 17.49 0.50 2.94

Researchers used Chromium Single Cell products and Xenium In Situ to profile how gene expression is spatially regulated during secondary palate formation PLEASANTON, Calif., June 27, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its Xenium In Situ platform was used in a study published in the Journal of Dental Research, offering novel insights into...Read more


Ryde Group partners with Mobile-health Network Solutions

June 27
Last Trade: 1.41 0.00 0.00

SINGAPORE / Jun 27, 2024 / Business Wire / Ryde Group Ltd (NYSE American: RYDE) ("Ryde" or "the Company"), a leading technology platform for mobility and quick commerce, today announced a partnership with Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr"), the first US listed telehealth provider in Asia Pacific. Ryde and MaNaDr signed a definitive partnership agreement to further collaboration in the telehealth and quick commerce...Read more


GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.

June 26
Last Trade: 7.71 -0.32 -3.99

Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription SANTA MONICA, Calif. / Jun 26, 2024 / Business Wire / Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-pocket prescription spending trends in the U.S. to help Americans better understand prescription...Read more


Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

June 26
Last Trade: 0.30 -0.01 -4.32

AXA is the 2nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume and Revenue AXA Represents the First Insurance Company to Approve Payment for Nociscan BROOMFIELD, CO, June 26, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and...Read more


iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research demonstrating the efficacy of its ProFound AI Risk algorithm in breast cancer risk assessment compared to traditional models at the upcoming Society for Imaging Informatics in Medicine (SIIM) Annual Meeting. The company will also highlight its...Read more


HEALWELL AI Announces Strategic Investment in xAI to Accelerate Development of Healthcare Focused Large Language Models That Benefit from xAI Developer Ecosystem

June 26
Last Trade: 2.38 0.00 0.00

HEALWELL completes USD $2,000,000 strategic investment into an xAI investment vehicle as part of its capital allocation strategy where it seeks to enhance and accelerate the development of its healthcare focused data science capabilities by partnering with world class platforms and seeking opportunities to integrate them with its own proprietary data and technology. HEALWELL has made this investment through Think 1st Principles...Read more


Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

June 25
Last Trade: 0.30 -0.01 -4.32

Established in 1932, the London Clinic is the UK’s Most Renowned Independent, Private Hospital Payment to Aclarion for Each Nociscan is Being Increased From the Original Contract Contract Extension Aligns Aclarion and The London Clinic With Engaging Payers to Increase Access to Nociscan for Both Patients and Referring Physicians BROOMFIELD, CO, June 25, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq:...Read more


Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures

June 24
Last Trade: 80.28 0.34 0.43

ALBUQUERQUE, N.M. / Jun 24, 2024 / Business Wire / Today Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (Nasdaq: GEHC) announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System (IGS) Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases (CVD). HHNM will use the...Read more


Teladoc Health’s predictive AI-modeling leads to increased engagement among diabetes members, driving additional A1c reduction, new research shows

June 24
Last Trade: 9.39 0.02 0.21

PURCHASE, NY, June 24, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, released new data today from two studies, presented at the American Diabetes Association’s 84th Scientific Sessions, that illustrate the company’s unmatched predictive modeling capabilities to help members with type 2 diabetes control their blood sugar through participation in Teladoc Health’s diabetes management...Read more


Progyny Announces Enhanced Global Services with Acquisition of Apryl

June 24
Last Trade: 28.95 0.77 2.73

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded in 2019. This acquisition enhances Progyny’s guided, concierge support that enables employees around the world to navigate the complexities of...Read more


HEALWELL AI's Pentavere Demonstrates Its DARWEN AI System Can Support Earlier Detection of Radiation Related Toxicities in Cancer Patients for Preventative Care

June 24
Last Trade: 2.38 0.00 0.00

Pentavere collaborated with Princess Margaret Cancer Centre's Radiation Oncology Department to assess the feasibility and accuracy of DARWEN™ AI to find patients experiencing radiation related toxicities based on information retrieved from electronic health records. The data and results from this groundbreaking AI research collaboration have been accepted for presentation at the American Society for Radiation Oncology in Washington DC...Read more


SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

June 24
Last Trade: 4.66 -0.05 -1.06

Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland, June 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced its new Residual Acute Myeloid (RAM) Application. The new offering expands the company's comprehensive...Read more


Sharecare enters into definitive agreement to be acquired by Altaris

June 21
Last Trade: 1.38 0.005 0.36

Sharecare shareholders to receive $1.43 per share in cash Transaction will deliver significant immediate cash value to stockholders upon closing, best positions Sharecare to continue to deliver exceptional service to clients and drive innovation ATLANTA, June 21, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, announced today that it has entered...Read more


GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology

June 20
Last Trade: 80.28 0.34 0.43

GE HealthCare and MediView XR, Inc. announce the first installation and clinical use of augmented reality solution OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minnesota. Heads-up holographic display aims to transform the interventional room and help advance the delivery of precision care across a variety of interventional procedures. CHICAGO / Jun 20, 2024 / Business Wire / Today GE HealthCare (Nasdaq:...Read more


Emergency Services Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments

June 20
Last Trade: 0.92 0.0085 0.94

SAN FRANCISCO, June 20, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that Emergency Services Inc., a physician-owned emergency medicine services group in Columbus, Ohio, is introducing Augmedix Go ED to physicians in the emergency department (ED) at the second-largest healthcare system in central Ohio. Augmedix Go ED is the industry’s first fully...Read more


Vita Global Sciences Partners with Veeva Systems to Streamline Clinical Data Management

June 19
Last Trade: 187.91 1.93 1.04

CRO will use Veeva Vault EDC to deliver a better experience to patients, research sites, and sponsors PLEASANTON, Calif., June 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Vita Global Sciences is partnering with Veeva to modernize its clinical data management processes and improve collaboration with key trial stakeholders. With Veeva Vault EDC, the CRO is establishing a foundation for study efficiency...Read more


Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game

June 18
Last Trade: 0.43 0.00 0.00

Clinically proven to improve attention function, EndeavorOTCⓇ is the first and only digital therapeutic cleared by FDA as an over-the-counter treatment for adults with ADHD BOSTON / Jun 18, 2024 / Business Wire / Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTCⓇ (AKL-T01) as an over-the-counter treatment for adults with...Read more


Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

RADNOR, Pa., June 17, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers. It combines generative AI, document templates, Microsoft Word integration, and structured content authoring tools. CoAuthor accelerates the creation of regulatory...Read more


R1 RCM to Host a Virtual Event “Technology Teach-In: A Deep Dive into Key Focus Areas and the R1 Platform” on June 27, 2024

June 17
Last Trade: 12.61 0.12 0.96

MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. The event will feature Steve Albert, Executive Vice President and Chief Product Officer,...Read more


Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

June 17
Last Trade: 7.52 -0.64 -7.84

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as...Read more


Sign Up To Get Daily Life Science Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB